Baker Bros. Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Baker Bros. Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-81,578	Closed	-$3.23M	–	100
2024 Q1	$3.23M	Buy	+81,578	New	+$2.41M	0.04%	67

Baker Bros. Advisors's ALPN Position: Q2 2024 in Review

Baker Bros. Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 81,578 shares — an estimated $3.23M sold.

Baker Bros. Advisors first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $3.23M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Baker Bros. Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Baker Bros. Advisors sold 81,578 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $3.23M.
Baker Bros. Advisors first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Baker Bros. Advisors's Alpine Immune Sciences Inc position peaked at $3.23M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Baker Bros. Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.